Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Stem Cell Rev Rep. 2017 Feb;13(1):79-91. doi: 10.1007/s12015-016-9696-y.
Stem cell therapy (SCT) raises the hope for cardiac regeneration in ischemic hearts. However, underlying molecular mechanisms for repair of dead myocardium by SCT in the ischemic heart is poorly understood. Growing evidences suggest that cardiac matrix stiffness and differential expressions of miRNAs play a crucial role in stem cell survival and differentiation. However, their roles on transplanted stem cells, for myocardial repair of the ischemic heart, remain unclear. Transplanted stem cells may act in an autocrine and/or paracrine manner to regenerate the dead myocardium. Paracrine mediators such as stem cell-derived exosomes are emerging as a novel therapeutic strategy to overcome some of the limitations of SCT. These exosomes carry microRNAs (miRNAs) that may regulate stem cell differentiation into a specific lineage. MicroRNAs may also contribute to stiffness of surrounding matrix by regulating extracellular matrix (ECM) turnover. The survival of transplanted stem cell depends on its autophagic process that maintains cellular homeostasis. Therefore, exosomes, miRNAs, extracellular matrix turnover, and autophagy may have an integral role in improving the efficacy of SCT. This review elaborates the specific roles of these regulatory components on cardiac regeneration in the ischemic heart during SCT.
干细胞治疗(SCT)为缺血性心脏中的心肌再生带来了希望。然而,SCT 修复缺血性心脏中死亡心肌的潜在分子机制仍不清楚。越来越多的证据表明,心脏基质硬度和 miRNA 的差异表达在干细胞的存活和分化中起着至关重要的作用。然而,它们在移植的干细胞对缺血性心脏的心肌修复中的作用尚不清楚。移植的干细胞可能通过自分泌和/或旁分泌的方式发挥作用,从而再生死亡的心肌。旁分泌介质,如干细胞衍生的外泌体,作为一种新的治疗策略出现,以克服 SCT 的一些局限性。这些外泌体携带 microRNAs(miRNAs),可以调节干细胞分化为特定谱系。miRNAs 也可以通过调节细胞外基质(ECM)的周转来影响周围基质的硬度。移植的干细胞的存活取决于其自噬过程,该过程维持细胞内稳态。因此,外泌体、miRNAs、细胞外基质周转和自噬可能在提高 SCT 的疗效方面发挥着整体作用。这篇综述阐述了这些调节成分在 SCT 期间对缺血性心脏中心肌再生的具体作用。